日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy

双特异性T细胞重定向抗体治疗后心血管不良事件

Martinello, Chiara; Verhoeyen, Els; Grunblatt, Eli; Alkhalili, Sawsan A; Meng, Zhiying; Baldridge, Abigail S; Dinner, Shira; Gordon, Leo I; Mehta, Jayesh; Rao, Anjali; Singhal, Seema; Karmali, Reem; Akhter, Nausheen

Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy

双特异性T细胞重定向抗体治疗后心血管不良事件

Assefa, Mahlet; Zelnick, Leila R; Kestenbaum, Bryan; De Wolski, Karen S; Bansal, Nisha; Grunblatt, Eli; Alkhalili, Sawsan A; Meng, Zhiying; Baldridge, Abigail S; Dinner, Shira; Gordon, Leo I; Mehta, Jayesh; Rao, Anjali; Singhal, Seema; Karmali, Reem; Akhter, Nausheen

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium

CAR-T细胞疗法治疗大B细胞淋巴瘤失败后双特异性抗体的疗效:来自ABC联盟的研究结果

Melody, Megan; Grover, Natalie; Franco, Stephanie; Romancik, Jason; Cortese, Matthew; Moyo, Tamara K; Bhansali, Rahul S; Ollila, Thomas; Kenkre, Vaishalee; Fitzgerald, Lindsey; Hess, Brian; Matasar, Matt; Shouse, Geoffrey; Annunzio, Kaitlin; Herr, Megan M; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Ma, Shuo; Winter, Jane N; Lin, Adam; Danilov, Alexey; Roy, Ishan; Barta, Stefan K; Gordon, Leo I; Stephens, Deborah; Cohen, Jonathon B; Epperla, Narendranath; Karmali, Reem

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium

CAR-T方案作为侵袭性B细胞淋巴瘤二线、三线、四线及以上治疗的疗效:来自ABC联盟的真实世界证据

Wang, John S; Ellsworth, Brandon L; Melody, Megan; Epperla, Narendranath; Stephens, Deborah; Romancik, Jason; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Herr, Megan M; Davis, James; Jesme, Christy; Pelcovits, Ari R; Moreira, Jonathan; Lin, Adam Y; Ma, Shuo; Winter, Jane N; Danilov, Alexey V; Shah, Nirav N; Barta, Stefan K; Cohen, Jonathon B; Gordon, Leo I; Grover, Natalie; Karmali, Reem

Recurrent Myocarditis After COVID Vaccination in a Patient With FLNC Mutation Undergoing Treatment for Lymphoma

一名携带FLNC基因突变且正在接受淋巴瘤治疗的患者在接种新冠疫苗后出现复发性心肌炎

Singh, Supreet; Campbell, Lucy C; Okwuosa, Ike S; Wilsbacher, Lisa D; Cremer, Paul C; Knight, Bradley P; Gordon, Leo I; Akhter, Nausheen

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

双重打击和双重表达淋巴瘤:CD19靶向CAR T细胞疗法生存结果的多中心分析

Karmali, Reem; Shouse, Geoffrey; Torka, Pallawi; Moyo, Tamara K; Romancik, Jason; Barta, Stefan K; Bhansali, Rahul; Cohen, Jonathon B; Shah, Nirav N; Zurko, Joanna; Kenkre, Vaishalee P; Hess, Brian; Stephens, Deborah M; Fitzgerald, Lindsey; Ollila, Thomas; Tabiti, Bukky; Roy, Ishan; Ma, Shuo; Winter, Jane; Pro, Barbara; Moreira, Jonathan; Danilov, Alexey V; David, Kevin; Gordon, Leo I; Epperla, Narendranath

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

CRISPR筛选揭示了一种同时靶向降低癌细胞硒含量和增加脂质氧化以诱导铁死亡的机制

Lamperis Sophia M, McMahon Kaylin M, Calvert Andrea E, Rink Jonathan S, Vasan Karthik, Pandkar Madhura R, Crentsil Eliana U, Chalmers Zachary R, McDonald Natalie R, Kosmala Cameron J, Bonini Marcelo G, Matei Daniela, Gordon Leo I, Chandel Navdeep S, Thaxton C Shad

Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1.

利用有机核心高密度脂蛋白样纳米颗粒封装和递送激酶抑制剂PIK-75靶向清道夫受体B类1型

Rink Jonathan S, Lin Adam Y, Calvert Andrea E, Kwon David, Moxley Alexandra, Henrich Stephen E, Mohammadlou Aliakbar, Zhang Xu Hannah, Wu Xiwei, Querfeld Christiane, Griend Donald J Vander, Yin Hongwei Holly, Horne David A, Nguyen SonBinh T, Rosen Steven T, Gordon Leo I, Thaxton Colby Shad

Comparative efficacy of lisocabtagene maraleucel in the PILOT study versus second-line chemotherapy regimens in the real world

PILOT 研究中 lisocabtagene maraleucel 与真实世界中二线化疗方案的疗效比较

Ghosh, Nilanjan; Sehgal, Alison; Liu, Fei Fei; Kostic, Ana; Crotta, Alessandro; De Benedetti, Marc; Faccone, Jillian; Peng, Lily; Gordon, Leo I

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

利索卡巴吉内马拉鲁塞用于不适合接受造血干细胞移植的复发/难治性大B细胞淋巴瘤患者:2期试点研究的最终结果

Sehgal, Alison; Hoda, Daanish; Riedell, Peter A; Ghosh, Nilanjan; Hamadani, Mehdi; Hildebrandt, Gerhard C; Godwin, John E; Reagan, Patrick M; Wagner-Johnston, Nina D; Essell, James; Nath, Rajneesh; Solomon, Scott R; Champion, Rebecca; Licitra, Edward; Fanning, Suzanne; Gupta, Neel K; Chow, Victor A; Yuan, Brenda; Yang, Zhi; Ogasawara, Ken; Thorpe, Jerill; Gordon, Leo I